ArticleScientific reports2025
Neighborhood walkability and cardiometabolic disease in Texas.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Linking walkability and pedestrian crossing safety using simulated urban environments.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiometabolic diseases (CMDs) affect significant numbers of adults in the United States, with 11% diagnosed with diabetes and 10% with cardiovascular diseases. Walking plays a crucial role in reducing health risks, particularly obesity and diabetes. We aim to explore the association between neighborhood walkability and CMD measures in Texas, while controlling for age, sex, racial/ethnic background, and family history of diabetes. We collected 1994 observations for the year 2019, merging data from the Texas Behavioral Risk Factor Surveillance System and the Environmental Protection Agency. We employed multilevel linear regression and multilevel logistic regression analyses to assess the association between CMD measures and neighborhood walkability. Our findings revealed that higher neighborhood walkability is significantly associated with a lower body mass index (BMI) (β = - 0.28, CI - 0.45 to - 0.10) and a reduced risk of diabetes (OR 0.93, CI 0.86-0.99), indicating that when walkability increases by one unit, an individual's BMI decreases by 0.28 kg/m
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.